FDA Approves Injectable Ceftobiprole Medocaril Sodium To Treat S. Aureus Bacteremia

MedPage Today (4/3, Frieden) reports, “The FDA approved the injectable drug ceftobiprole medocaril sodium (Zevtera) to treat adults with Staphylococcus aureus bacteremia (SAB), the agency announced Wednesday.” The medication “is indicated for people with right-sided infective endocarditis, those with acute bacterial skin and skin structure infections (ABSSSI), and adult and pediatric patients 3 months to less than 18 years old with community-acquired bacterial pneumonia (CABP).”